研究表明,糖尿病预防计划可将T2D的发病率降低20%

Iskandar Idris
{"title":"研究表明,糖尿病预防计划可将T2D的发病率降低20%","authors":"Iskandar Idris","doi":"10.1002/doi2.45","DOIUrl":null,"url":null,"abstract":"<p>In England, the NHS Diabetes Prevention Programme is offered to adults with pre-diabetes, with lifestyle advice to help reduce the risk of developing type 2 diabetes. The programme is intended to reduce the yearly cost of type 2 diabetes to the NHS by £8.8 billion, which is almost 9% of its budget, according to Diabetes UK.</p><p>People with pre-diabetes are particularly at high risk of developing type 2 diabetes mellitus. Researchers from the University of Manchester have therefore set out to investigate whether people who were referred to the programme were less likely to develop type 2 diabetes, compared with those who were not referred to the programme. To do this, the investigators used a cohort study of patients attending primary care in England using clinical Practice Research Datalink data from 1 April 2016 (NHS Diabetes Prevention Programme introduction) to 31 March 2020. Patients referred to the programme from referring practices were matched to patients in non-referring practices to minimize confounding. Patients were matched based on age, sex, and date of pre-diabetes diagnosis (within 365 days). Analysis was adjusted for age (at index date), sex, time from pre-diabetes diagnosis to index date, BMI, HbA1c, total serum cholesterol, systolic blood pressure, diastolic blood pressure, prescription of metformin, smoking status, socioeconomic status, a diagnosis of depression, and comorbidities.</p><p>A total of 18 470 patients referred to the NHS Diabetes Prevention Programme were matched with 51 331 patients not referred to NHS Diabetes Prevention Programme in the main analysis. Mean follow-up from referral was 482.0 and 472.4 days, respectively.</p><p>The researchers identified that the risk of developing type 2 diabetes was 20% lower in people with raised blood sugars referred to the programme, compared with people who were not referred and who received usual care.</p><p>While caution is needed to fully interpret the findings of this observational study, findings from the study supported the overall effectiveness of the programme. In addition, it would support the decision of the ‘rapid large-scale implementation’ of the programme in England, rather than a slower or regional introduction, as well as the continuation of the programme and the introduction of similar programmes to the rest of the United Kingdom.</p>","PeriodicalId":100370,"journal":{"name":"Diabetes, Obesity and Metabolism Now","volume":"1 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/doi2.45","citationCount":"0","resultStr":"{\"title\":\"Study shows diabetes prevention programme reduced development of T2D by 20%\",\"authors\":\"Iskandar Idris\",\"doi\":\"10.1002/doi2.45\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>In England, the NHS Diabetes Prevention Programme is offered to adults with pre-diabetes, with lifestyle advice to help reduce the risk of developing type 2 diabetes. The programme is intended to reduce the yearly cost of type 2 diabetes to the NHS by £8.8 billion, which is almost 9% of its budget, according to Diabetes UK.</p><p>People with pre-diabetes are particularly at high risk of developing type 2 diabetes mellitus. Researchers from the University of Manchester have therefore set out to investigate whether people who were referred to the programme were less likely to develop type 2 diabetes, compared with those who were not referred to the programme. To do this, the investigators used a cohort study of patients attending primary care in England using clinical Practice Research Datalink data from 1 April 2016 (NHS Diabetes Prevention Programme introduction) to 31 March 2020. Patients referred to the programme from referring practices were matched to patients in non-referring practices to minimize confounding. Patients were matched based on age, sex, and date of pre-diabetes diagnosis (within 365 days). Analysis was adjusted for age (at index date), sex, time from pre-diabetes diagnosis to index date, BMI, HbA1c, total serum cholesterol, systolic blood pressure, diastolic blood pressure, prescription of metformin, smoking status, socioeconomic status, a diagnosis of depression, and comorbidities.</p><p>A total of 18 470 patients referred to the NHS Diabetes Prevention Programme were matched with 51 331 patients not referred to NHS Diabetes Prevention Programme in the main analysis. Mean follow-up from referral was 482.0 and 472.4 days, respectively.</p><p>The researchers identified that the risk of developing type 2 diabetes was 20% lower in people with raised blood sugars referred to the programme, compared with people who were not referred and who received usual care.</p><p>While caution is needed to fully interpret the findings of this observational study, findings from the study supported the overall effectiveness of the programme. In addition, it would support the decision of the ‘rapid large-scale implementation’ of the programme in England, rather than a slower or regional introduction, as well as the continuation of the programme and the introduction of similar programmes to the rest of the United Kingdom.</p>\",\"PeriodicalId\":100370,\"journal\":{\"name\":\"Diabetes, Obesity and Metabolism Now\",\"volume\":\"1 5\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/doi2.45\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes, Obesity and Metabolism Now\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/doi2.45\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity and Metabolism Now","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/doi2.45","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

在英格兰,NHS糖尿病预防计划向糖尿病前期的成年人提供,并提供生活方式建议,以帮助降低患2型糖尿病的风险。根据英国糖尿病协会的数据,该计划旨在将英国国家医疗服务体系每年2型糖尿病的费用减少88亿英镑,几乎占其预算的9%。糖尿病前期患者尤其容易患2型糖尿病。因此,曼彻斯特大学的研究人员开始调查,与未被转介该项目的人相比,被转介参加该项目的人们是否不太可能患上2型糖尿病。为了做到这一点,研究人员使用了2016年4月1日(英国国家医疗服务体系糖尿病预防计划介绍)至2020年3月31日的临床实践研究数据链数据,对在英格兰接受初级保健的患者进行了队列研究。从转诊诊所转诊到该项目的患者与非转诊诊所的患者进行匹配,以最大限度地减少混淆。根据年龄、性别和糖尿病前期诊断日期对患者进行匹配(365天内 天)。分析根据年龄(指标日期)、性别、从糖尿病前期诊断到指标日期的时间、BMI、HbA1c、血清总胆固醇、收缩压、舒张压、二甲双胍处方、吸烟状况、社会经济状况、抑郁症诊断和合并症进行了调整。共18 470名转诊至英国国家医疗服务体系糖尿病预防计划的患者与51名患者匹配 在主要分析中,331名患者未被转介至NHS糖尿病预防计划。转诊后的平均随访时间分别为482.0和472.4 天。研究人员发现,与未被转诊和接受常规护理的人相比,被转诊的血糖升高的人患2型糖尿病的风险低20%。虽然需要谨慎地充分解释这项观察性研究的结果,但该研究的结果支持了该计划的总体有效性。此外,它将支持在英格兰“迅速大规模实施”该方案的决定,而不是缓慢或区域性地实施,以及继续实施该方案并在联合王国其他地区实施类似的方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Study shows diabetes prevention programme reduced development of T2D by 20%

In England, the NHS Diabetes Prevention Programme is offered to adults with pre-diabetes, with lifestyle advice to help reduce the risk of developing type 2 diabetes. The programme is intended to reduce the yearly cost of type 2 diabetes to the NHS by £8.8 billion, which is almost 9% of its budget, according to Diabetes UK.

People with pre-diabetes are particularly at high risk of developing type 2 diabetes mellitus. Researchers from the University of Manchester have therefore set out to investigate whether people who were referred to the programme were less likely to develop type 2 diabetes, compared with those who were not referred to the programme. To do this, the investigators used a cohort study of patients attending primary care in England using clinical Practice Research Datalink data from 1 April 2016 (NHS Diabetes Prevention Programme introduction) to 31 March 2020. Patients referred to the programme from referring practices were matched to patients in non-referring practices to minimize confounding. Patients were matched based on age, sex, and date of pre-diabetes diagnosis (within 365 days). Analysis was adjusted for age (at index date), sex, time from pre-diabetes diagnosis to index date, BMI, HbA1c, total serum cholesterol, systolic blood pressure, diastolic blood pressure, prescription of metformin, smoking status, socioeconomic status, a diagnosis of depression, and comorbidities.

A total of 18 470 patients referred to the NHS Diabetes Prevention Programme were matched with 51 331 patients not referred to NHS Diabetes Prevention Programme in the main analysis. Mean follow-up from referral was 482.0 and 472.4 days, respectively.

The researchers identified that the risk of developing type 2 diabetes was 20% lower in people with raised blood sugars referred to the programme, compared with people who were not referred and who received usual care.

While caution is needed to fully interpret the findings of this observational study, findings from the study supported the overall effectiveness of the programme. In addition, it would support the decision of the ‘rapid large-scale implementation’ of the programme in England, rather than a slower or regional introduction, as well as the continuation of the programme and the introduction of similar programmes to the rest of the United Kingdom.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Issue Information Precision medicine approach to detect obese people who are at high risk of developing diabetes Increasing excess to weight loss injection shown to save thousands of lives a year Semaglutide shown to improve cardiovascular outcomes among patients with type 2 diabetes with any forms of heart failure Real world study provided reassurance of the safety of GLP-1 therapy on mental health and suicide risk
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1